The startup develops vitro diagnostic products utilizing lateral flow and magnetic particle chemiluminescence technologies for laboratory and point-of-care testing. Their solutions enable early screening for cancer and Alzheimer's disease, as well as accurate testing for respiratory, intestinal, and parasitic diseases, addressing critical gaps in timely medical diagnostics.
Funding
Funding not disclosed
Founders
Product
Problem
Early and accurate diagnostic testing for diseases like cancer, Alzheimer's, and various infectious diseases is often hindered by the limitations of traditional laboratory-based methods and point-of-care testing options. Existing diagnostic solutions may lack the speed, accessibility, or sensitivity needed for timely medical intervention.
Solution
Hongyutai Biotechnology develops in-vitro diagnostic (IVD) products based on lateral flow and magnetic particle chemiluminescence technologies, enabling rapid and precise detection of various diseases. The company's diagnostic solutions facilitate early screening for conditions such as cancer and Alzheimer's disease, as well as accurate testing for respiratory, intestinal, and parasitic infections. These technologies offer improved sensitivity and speed compared to traditional methods, leading to earlier diagnosis and more effective treatment.
Target Audience
The primary target audience includes clinical laboratories, hospitals, point-of-care testing facilities, and healthcare providers requiring rapid and accurate diagnostic tools.
Features
- Lateral flow assays for rapid detection of infectious diseases and other conditions
- Magnetic particle chemiluminescence assays for high-sensitivity detection of biomarkers
- Diagnostic kits for COVID-19 antigen detection (colloidal gold method)
- Multiplex assays for simultaneous detection of influenza A/B and COVID-19 antigens
- Reagents for inflammation testing (magnetic particle chemiluminescence immunoassay)
- Reagents for cardiac marker testing (magnetic particle chemiluminescence)
- Reagents for diabetes testing (magnetic particle chemiluminescence and fluorescence immunochromatography)
- Reagents for tumor marker testing (magnetic particle chemiluminescence)